ibandronic acid monohydrate sodium
PolandDrugs containing this active substance
-
The medicine is used in adults in the case of breast cancer that has spread to the bones. It helps to prevent fractures and bone complications requiring surgery or radiation by inhibiting the loss of calcium from the bones.
Form: tablets, film-coated
Active substance Dosage ibandronic acid monohydrate sodium 56.25 mg ATC: M05BA06
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used for the treatment of postmenopausal osteoporosis. It helps to inhibit bone loss, increase bone mass, and reduce the risk of fractures (especially vertebral fractures).
Form: tablets, film-coated
Active substance Dosage ibandronic acid monohydrate sodium 169.32 mg ATC: M05BA06
Manufacturer: McDermott Laboratories Limited (t.a. Gerard Laboratories) Mylan Hungary Limited Pharma Pack Hungary Limited
-
The medicine is intended for the treatment of postmenopausal osteoporosis. It helps to inhibit bone loss and may reduce the risk of vertebral fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid monohydrate sodium 168.75 mg ATC: M05BA06
Manufacturer: Laboratorios Liconsa, S.A.
-
The medicine is used to treat postmenopausal osteoporosis to reduce the risk of bone fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid monohydrate sodium 168.75 mg ATC: M05BA06
Manufacturer: Zentiva, joint-stock company
-
The medicine is used to treat postmenopausal osteoporosis to inhibit bone loss and reduce the risk of fractures (especially vertebral fractures).
Form: tablets, film-coated
Active substance Dosage ibandronic acid monohydrate sodium 168.81 mg ATC: M05BA06
Manufacturer: Gedeon Richter Plc.